Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.280
-0.008 (-2.71%)
At close: Feb 27, 2026, 4:00 PM EST
0.294
+0.014 (4.93%)
After-hours: Feb 27, 2026, 4:21 PM EST
Cue Biopharma Employees
Cue Biopharma had 41 employees as of December 31, 2024. The number of employees decreased by 12 or -22.64% compared to the previous year.
Employees
41
Change (1Y)
-12
Growth (1Y)
-22.64%
Revenue / Employee
$173,171
Profits / Employee
-$919,098
Market Cap
25.56M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| IO Biotech | 78 |
| IGC Pharma | 70 |
| Boundless Bio | 64 |
| Evaxion | 46 |
| Senti Biosciences | 34 |
| Daré Bioscience | 23 |
| Skye Bioscience | 16 |
| Reviva Pharmaceuticals Holdings | 14 |
CUE News
- 11 days ago - Cue Biopharma Announces Preclinical Safety and Tolerability Data for CUE-401 for the Treatment of Autoimmune and Inflammatory Diseases - GlobeNewsWire
- 16 days ago - Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer - GlobeNewsWire
- 2 months ago - Cue Biopharma Announces Pricing of $10 Million Public Offering - GlobeNewsWire
- 2 months ago - Cue Biopharma Announces Proposed Public Offering - GlobeNewsWire
- 3 months ago - Cue Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 4 months ago - Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors - GlobeNewsWire
- 5 months ago - Cue Biopharma Announces Strategic Transition in Leadership to Further Enable Next Stage of Growth with Disruptive Autoimmune Therapeutic Candidates - GlobeNewsWire
- 6 months ago - Cue Biopharma to Participate in Fireside Chat at the Cantor Global Healthcare Conference - GlobeNewsWire